<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/1395cc–5" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/1395cc–5/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/1395cc–5/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1395cc_5"><akn:num>1395cc–5</akn:num><akn:heading>Independence at home medical practice demonstration program</akn:heading><akn:content><akn:p>§ 1395cc–5. Independence at home medical practice demonstration program(a) Establishment(1) In generalThe Secretary shall conduct a demonstration program (in this section referred to as the “demonstration program”) to test a payment incentive and service delivery model that utilizes physician and nurse practitioner directed home-based primary care teams designed to reduce expenditures and improve health outcomes in the provision of items and services under this subchapter to applicable beneficiaries (as defined in subsection (d)).


(2) RequirementThe demonstration program shall test whether a model described in paragraph (1), which is accountable for providing comprehensive, coordinated, continuous, and accessible care to high-need populations at home and coordinating health care across all treatment settings, results in—(A) reducing preventable hospitalizations;

(B) preventing hospital readmissions;

(C) reducing emergency room visits;

(D) improving health outcomes commensurate with the beneficiaries’ stage of chronic illness;

(E) improving the efficiency of care, such as by reducing duplicative diagnostic and laboratory tests;

(F) reducing the cost of health care services covered under this subchapter; and

(G) achieving beneficiary and family caregiver satisfaction.



(b) Independence at home medical practice(1) Independence at home medical practice definedIn this section:(A) In generalThe term “independence at home medical practice” means a legal entity that—(i) is comprised of an individual physician or nurse practitioner or group of physicians and nurse practitioners that provides care as part of a team that includes physicians, nurses, physician assistants, pharmacists, and other health and social services staff as appropriate who have experience providing home-based primary care to applicable beneficiaries, make in-home visits, and are available 24 hours per day, 7 days per week to carry out plans of care that are tailored to the individual beneficiary</akn:p></akn:content><akn:subsection eId="subsec_1395cc_5_a"><akn:num>(a)</akn:num><akn:heading>Establishment</akn:heading><akn:content><akn:p>(a) Establishment</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395cc_5_b"><akn:num>(b)</akn:num><akn:heading>Independence at home medical practice</akn:heading><akn:content><akn:p>(b) Independence at home medical practice</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395cc_5_c"><akn:num>(c)</akn:num><akn:heading>Payment methodology</akn:heading><akn:content><akn:p>(c) Payment methodology</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395cc_5_d"><akn:num>(d)</akn:num><akn:heading>Applicable beneficiaries</akn:heading><akn:content><akn:p>(d) Applicable beneficiaries</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395cc_5_e"><akn:num>(e)</akn:num><akn:heading>Implementation</akn:heading><akn:content><akn:p>(e) Implementation</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395cc_5_f"><akn:num>(f)</akn:num><akn:heading>Evaluation and monitoring</akn:heading><akn:content><akn:p>(f) Evaluation and monitoring</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395cc_5_g"><akn:num>(g)</akn:num><akn:heading>Reports to Congress</akn:heading><akn:content><akn:p>(g) Reports to Congress The Secretary shall conduct an independent evaluation of the demonstration program and submit to Congress a final report, including best practices under the demonstration program, including, to the extent practicable, with respect to the use of electronic health information systems, as described in subsection (b)(1)(A)(vi). Such report shall include an analysis of the demonstration program on coordination of care, expenditures under this subchapter, applicable beneficiary access to services, and the quality of health care services provided to applicable beneficiaries.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395cc_5_h"><akn:num>(h)</akn:num><akn:heading>Funding</akn:heading><akn:content><akn:p>(h) Funding For purposes of administering and carrying out the demonstration program, other than for payments for items and services furnished under this subchapter and incentive payments under subsection (c), in addition to funds otherwise appropriated, there shall be transferred to the Secretary for the Center for Medicare &amp; Medicaid Services Program Management Account from the Federal Hospital Insurance Trust Fund under section 1395i of this title and the Federal Supplementary Medical Insurance Trust Fund under section 1395t of this title (in proportions determined appropriate by the Secretary) $5,000,000 for each of fiscal years 2010 through 2015 and $9,000,000 for fiscal year 2021. Amounts transferred under this subsection for a fiscal year shall be available until expended.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1395cc_5_i"><akn:num>(i)</akn:num><akn:heading>Termination</akn:heading><akn:content><akn:p>(i) Termination</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>